Reaction Details Report a problem with these data
Target
Mu-type opioid receptor
Ligand
BDBM469461
Substrate
n/a
Meas. Tech.
Human Mu-Opioid Peptide (hMOP) Receptor Binding Assay
Ki
1.000±n/a nM
Citation
 Kuehnert, S; Koenigs, R; Kless, A; Wegert, A; Konetzki, I; Ratcliffe, P; Jostock, R; Koch, T; Linz, K; Schroeder, W 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives US Patent  US10807988 Publication Date 10/20/2020 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM469461
Synonyms:
US10807988, Example SC_3103 | cis-1-(Cyclobutyl-methyl)-8-dimethylamino-3-[4-methyl-6-(trifluoromethyl)- pyridin-3-yl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one
Type:
Small organic molecule
Emp. Form.:
C28H35F3N4O
Mol. Mass.:
500.5989
SMILES:
CN(C)[C@]1(CC[C@]2(CN(C(=O)N2CC2CCC2)c2cnc(cc2C)C(F)(F)F)CC1)c1ccccc1 |r,wU:6.11,3.2,(4.04,-5.47,;4.81,-6.8,;6.35,-6.8,;4.04,-8.13,;3.27,-9.47,;1.73,-9.47,;.96,-8.13,;.06,-6.89,;-1.41,-7.36,;-1.41,-8.9,;-2.65,-9.81,;.06,-9.38,;.53,-10.84,;-.5,-11.99,;-2.04,-11.99,;-2.04,-13.53,;-.5,-13.53,;-2.74,-6.59,;-4.07,-7.36,;-5.41,-6.59,;-5.41,-5.05,;-4.07,-4.28,;-2.74,-5.05,;-1.41,-4.28,;-6.74,-4.28,;-8.07,-3.51,;-5.97,-2.95,;-7.51,-5.62,;1.73,-6.8,;3.27,-6.8,;4.81,-9.47,;4.04,-10.8,;4.81,-12.14,;6.35,-12.14,;7.12,-10.8,;6.35,-9.47,)|
Structure:
Search PDB for entries with ligand similarity: